VERU INC. (VERU)
About VERU INC.
Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2024
- $16.9M
- Net income
- -$22.7M
- Total assets
- $29.8M
- Market cap
- $36.1M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $36.1M
- Dividend yield
- 12.5%
- Shares outstanding
- 16.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 1, 1990
Veru Inc. (VERU) Stock Price
- Reported a net loss of $22.7M in FY2024.
- Trading 49% below its 52-week high.
- Pays a dividend yielding about 12.5% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review VERU INC..
Write a review
News about VERU INC.
News & sentiment via Polygon.io
Veru Inc.: frequently asked questions
Is Veru Inc. an American company?
Veru Inc. is a US-based company headquartered in Miami, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Veru Inc. headquartered?
Veru Inc. is headquartered in Miami, Florida, United States.
Is Veru Inc. publicly traded?
Yes — Veru Inc. is a publicly traded company. Its stock trades under the ticker symbol VERU on the NASDAQ.
What does Veru Inc. do?
Veru Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
